NCT06713395Completed
PERMA-Based Intervention on Negative Emotions, Adherence, and Complications in Postoperative Glioma Patients
Analysis of the Effects of PERMA-Based Integrated Psychological Intervention on Negative Emotions, Treatment Adherence, and Complications in Postoperative Glioma Patients
Source: ClinicalTrials.gov · Last updated 3 Dec 2024
Brief summary (registry, in English)
The goal of this clinical trial is to evaluate whether a PERMA-based integrated psychological intervention can reduce negative emotions, enhance treatment adherence, and decrease the risk of complications in postoperative glioma patients. The main questions it aims to answer are: Can the PERMA-based psychological intervention significantly improve anxiety and depression scores in postoperative glioma patients? Does the intervention improve treatment adherence, reduce complications, and enhance quality of life compared to standard care? Researchers will compare an observation group receiving the PERMA-based psychological intervention to a control group receiving standard postoperative care to see if the intervention improves patient outcomes. Participants will: Receive either standard postoperative care (control group) or PERMA-based psychological intervention for one month (observation group). Be assessed on: Self-Rating Depression Scale (SDS) and Self-Rating Anxiety Scale (SAS). Treatment Adherence Scale and Complication Record Form. Quality of Life Scale. Be followed for complications using Kaplan-Meier survival analysis.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 124 (actual)
- First submitted
- 22 Nov 2024
- Start date
- 10 Jan 2022
- Primary completion date
- 15 Feb 2024
- Lead sponsor
- Yang Huang
- Diseases
- Childhood cancers
- NCT number
- NCT06713395
What you commit to
- Study type: Interventional
- Participants enrolled: 124
- From 10 Jan 2022 to the primary completion date, 15 Feb 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- ①Concurrent diagnosis of other malignant tumors;
Other illness
- ②Coexisting cognitive impairment or other psychiatric disorders;
- ③Combined liver or kidney dysfunction, immune system disorders, or other severe diseases;
- ④Presence of infectious diseases;
Other
- ⑤Pregnant or breastfeeding women.
Who the study is looking for
- ①Meeting the relevant diagnostic criteria from the 5th edition of the World Health Organization Classification of Central Nervous System (CNS) Tumors, and confirmed through postoperative pathological examination;
- ②Underwent surgical treatment;
- ③Clear consciousness, with good communication ability, and capable of cooperating with healthcare personnel to complete the study;
- ④Complete clinical data.
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Affiliated Brain Hospital of Nanjing Medical University Coordinator of this site? Confirm its status | Nanjing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.